DK1651223T3 - 2-Methoxymethyl-3-(3,4-dichlorphenyl)azabicyclo[3.2.1]octantartratsalt - Google Patents

2-Methoxymethyl-3-(3,4-dichlorphenyl)azabicyclo[3.2.1]octantartratsalt

Info

Publication number
DK1651223T3
DK1651223T3 DK04766360T DK04766360T DK1651223T3 DK 1651223 T3 DK1651223 T3 DK 1651223T3 DK 04766360 T DK04766360 T DK 04766360T DK 04766360 T DK04766360 T DK 04766360T DK 1651223 T3 DK1651223 T3 DK 1651223T3
Authority
DK
Denmark
Prior art keywords
octantartratsalt
azabicyclo
dichlorophenyl
methoxymethyl
Prior art date
Application number
DK04766360T
Other languages
English (en)
Inventor
Brian Frostrup
Frank Waetjen
Klaus Snej Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK1651223T3 publication Critical patent/DK1651223T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04766360T 2003-07-31 2004-07-29 2-Methoxymethyl-3-(3,4-dichlorphenyl)azabicyclo[3.2.1]octantartratsalt DK1651223T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301117 2003-07-31
US49409003P 2003-08-12 2003-08-12
PCT/EP2004/051651 WO2005011694A1 (en) 2003-07-31 2004-07-29 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts

Publications (1)

Publication Number Publication Date
DK1651223T3 true DK1651223T3 (da) 2007-06-11

Family

ID=36701727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04766360T DK1651223T3 (da) 2003-07-31 2004-07-29 2-Methoxymethyl-3-(3,4-dichlorphenyl)azabicyclo[3.2.1]octantartratsalt

Country Status (22)

Country Link
US (1) US7700619B2 (da)
EP (1) EP1651223B1 (da)
JP (1) JP4711961B2 (da)
CN (1) CN100427484C (da)
AR (1) AR045141A1 (da)
AT (1) ATE355060T1 (da)
AU (1) AU2004260837C1 (da)
BR (1) BRPI0413035A (da)
CA (1) CA2534295A1 (da)
DE (1) DE602004005048T2 (da)
DK (1) DK1651223T3 (da)
ES (1) ES2281827T3 (da)
MY (1) MY140105A (da)
NZ (1) NZ544957A (da)
PL (1) PL1651223T3 (da)
PT (1) PT1651223E (da)
RU (1) RU2348631C2 (da)
SI (1) SI1651223T1 (da)
TW (1) TW200507844A (da)
UA (1) UA86025C2 (da)
WO (1) WO2005011694A1 (da)
ZA (1) ZA200600756B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006738A2 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
EP1779851A1 (en) * 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
CN116144016B (zh) * 2021-11-23 2025-02-14 上海新阳半导体材料股份有限公司 一种193nm干法光刻胶用添加剂及其制备方法和应用
CN116144014B (zh) * 2021-11-23 2025-02-14 上海新阳半导体材料股份有限公司 一种193nm干法光刻胶用添加剂及其制备方法和应用
CN116144015B (zh) * 2021-11-23 2024-11-19 上海新阳半导体材料股份有限公司 一种193nm干法光刻胶用添加剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
GB8923209D0 (en) * 1989-10-14 1989-11-29 Wyeth John & Brother Ltd Heterocyclic compounds
BR9707636A (pt) * 1996-02-22 1999-07-27 Neurosearch As Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo
US7381733B2 (en) * 2001-11-30 2008-06-03 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases

Also Published As

Publication number Publication date
ATE355060T1 (de) 2006-03-15
AR045141A1 (es) 2005-10-19
RU2005141065A (ru) 2006-08-10
ZA200600756B (en) 2007-05-30
MY140105A (en) 2009-11-30
PL1651223T3 (pl) 2007-07-31
PT1651223E (pt) 2007-03-30
CN100427484C (zh) 2008-10-22
UA86025C2 (en) 2009-03-25
ES2281827T3 (es) 2007-10-01
AU2004260837A1 (en) 2005-02-10
US7700619B2 (en) 2010-04-20
EP1651223A1 (en) 2006-05-03
BRPI0413035A (pt) 2006-10-03
RU2348631C2 (ru) 2009-03-10
SI1651223T1 (sl) 2007-08-31
NZ544957A (en) 2009-02-28
WO2005011694A1 (en) 2005-02-10
AU2004260837C1 (en) 2010-08-19
JP4711961B2 (ja) 2011-06-29
JP2007509030A (ja) 2007-04-12
DE602004005048D1 (de) 2007-04-12
TW200507844A (en) 2005-03-01
DE602004005048T2 (de) 2007-08-16
US20070043075A1 (en) 2007-02-22
CA2534295A1 (en) 2005-02-10
CN1822837A (zh) 2006-08-23
EP1651223B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
DE602004006169D1 (de) Substituierte 8&#39;-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
EG25273A (en) Substituted dihydroquinazolines.
PT1373216E (pt) Derivados de 4,5-diidro-1h-pirazol que possuem actividade antagonista de cb1
ATE402152T1 (de) Hiv-inhibierende1,2,4-triazine
NL1027434A1 (nl) Bicyclische pyrazolyl- en imidazolylverbindingen, en toepassingen daarvan.
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
BR0302743B1 (pt) conjunto de travamento de unidade de plantio.
ATE355060T1 (de) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8- azabicyclo (3.2.1)octantartrat-salze
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
BRPI0402574B1 (pt) combinada agrìcola.
AP2006003515A0 (en) Fungicidal mixtures.
AP2005003369A0 (en) Knock-down drums.
AU2003254555A1 (en) S. aureus antigene
LU91022B1 (en) Sektionaltor.
IS8330A (is) 2-Metoxýmetýl-3-(3,4-díklórófenýl)-8-asabísýkló[3.2.1]oktan-tartrasölt
ITMI20040873A1 (it) Processo di preparazione di 3-3,4 metilendiossi-fenil-2-metilpropanale
AP2006003589A0 (en) Fungicidal mixtures.
ITMI20022028A1 (it) Fenton i.s.
ES1055317Y (es) Escenario autotransportable.
Reinhart Kišalōnā ha-vāday šel mapat ha-derekīm
Löfvander Jubilerande nätverk
Reinhart Mihūz latōdā’ayin lěPalestīnayīm’afīlū mezeg-’avīr
AP2006003547A0 (en) Fungicidal mixtures.
TJ20030779A (en) Dibaferrol, having antimicrobe activity.
ITBA20040040A1 (it) ELEFANTINO h.5,5